PHARMA CLINICAL SYSTEMS AS
Operating
Konsulenttjenester innenfor IT, prosjektledelse, kjøp salg av aksjer
og eiendom og annen tilhørende virksomhet.
Salg av konsulenttjenester innenfor IT, prosjektledelse, kjøp salg av
aksjer og eiendom og annen tilhørende virksomhet.
Organization
- CEO
- SA
Svein Arne Sørmo1961
- Chairman of the board
- SA
Svein Arne Sørmo1961
- Years since formation
- 12 years
- since Dec 3, 2014
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 2,801,410
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 1,245,755
- NOK
- Annual total result 2025
- -1,644,713
- NOK
- Total equity 2025
- 371,721
- NOK
Last update: May 6, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
SA 1961 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
SA 1961 | Chairman | 100 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
SA 1961 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
SA 1961 | Ordinary shares | 2,801,410 | 100 % |
Shares owned by the PHARMA CLINICAL SYSTEMS AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
I Under liquidation | Ordinary shares | 242,529 | 21.77 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 1,245,755 | 1,341,700 | 1,030,000 | 76,000 | 54,800 |
Annual Total Result | -1,644,713 | 422,390 | 538,910 | 82,839 | 19,745 |
Total assets | 621,438 | 2,586,199 | 2,116,991 | 1,690,773 | 1,786,077 |
Total liabilities | 249,717 | 369,766 | 212,948 | 325,639 | 482,955 |
Total equity | 371,721 | 2,216,434 | 1,904,043 | 1,365,134 | 1,303,121 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 1,245,755 | 1,341,700 | 1,030,000 | 76,000 | 54,800 |
Total operating costs | 709,263 | 796,922 | 394,460 | 50,417 | 35,055 |
Operating result | 536,492 | 544,778 | 635,540 | 25,583 | 19,745 |
Financial income/costs | -2,061,505 | -2,264 | -137 | 57,256 | 0 |
Profit before tax | -1,525,013 | 542,514 | 635,403 | 82,839 | 19,745 |
Total tax & extraordinary income/cost | 119,700 | 120,124 | 96,493 | 0 | 0 |
Annual Total Result | -1,644,713 | 422,390 | 538,910 | 82,839 | 19,745 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 1,887,326 | 1,687,256 | 1,306,298 | 1,630,000 |
Total current assets | 621,438 | 698,873 | 429,735 | 384,474 | 156,077 |
Total assets | 621,438 | 2,586,199 | 2,116,991 | 1,690,773 | 1,786,077 |
Short term debt | 219,717 | 339,766 | 167,498 | 28,096 | 23,464 |
Long term debt | 30,000 | 30,000 | 45,449 | 297,543 | 459,491 |
Total liabilities | 249,717 | 369,766 | 212,948 | 325,639 | 482,955 |
Contributed capital | 371,721 | 1,262,550 | 1,262,550 | 1,262,550 | 1,283,376 |
Retained earnings | 0 | 953,884 | 641,494 | 102,584 | 19,745 |
Total equity | 371,721 | 2,216,434 | 1,904,043 | 1,365,134 | 1,303,121 |
Total equity and liabilities | 621,438 | 2,586,199 | 2,116,991 | 1,690,773 | 1,786,077 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises